BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

433 related articles for article (PubMed ID: 15022280)

  • 1. Restaging surgery for women with borderline ovarian tumors: results of a French multicenter study.
    Fauvet R; Boccara J; Dufournet C; David-Montefiore E; Poncelet C; Daraï E
    Cancer; 2004 Mar; 100(6):1145-51. PubMed ID: 15022280
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The recurrence and the overall survival rates of ovarian serous borderline neoplasms with noninvasive implants is time dependent.
    Silva EG; Gershenson DM; Malpica A; Deavers M
    Am J Surg Pathol; 2006 Nov; 30(11):1367-71. PubMed ID: 17063075
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Laparoscopic restaging of borderline ovarian tumors.
    Daraï E; Tulpin L; Prugnolle H; Cortez A; Dubernard G
    Surg Endosc; 2007 Nov; 21(11):2039-43. PubMed ID: 17514402
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Long-term outcomes following conservative surgery for borderline tumor of the ovary: a large population-based study.
    Suh-Burgmann E
    Gynecol Oncol; 2006 Dec; 103(3):841-7. PubMed ID: 16793124
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Borderline ovarian tumors: an update].
    Tulpin L; Rouzier R; Morel O; Malartic C; Daraï E; Barranger E
    Gynecol Obstet Fertil; 2008 Apr; 36(4):422-9. PubMed ID: 18356093
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fertility after conservative treatment for borderline ovarian tumors: a French multicenter study.
    Fauvet R; Poncelet C; Boccara J; Descamps P; Fondrinier E; Daraï E
    Fertil Steril; 2005 Feb; 83(2):284-90; quiz 525-6. PubMed ID: 15705364
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The role of restaging borderline ovarian tumors: single institution experience and review of the literature.
    Zapardiel I; Rosenberg P; Peiretti M; Zanagnolo V; Sanguineti F; Aletti G; Landoni F; Bocciolone L; Colombo N; Maggioni A
    Gynecol Oncol; 2010 Nov; 119(2):274-7. PubMed ID: 20797775
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Recurrence after cystectomy for borderline ovarian tumors: results of a French multicenter study.
    Poncelet C; Fauvet R; Boccara J; Daraï E
    Ann Surg Oncol; 2006 Apr; 13(4):565-71. PubMed ID: 16491337
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Retroperitoneal nodal metastasis in primary and recurrent granulosa cell tumors of the ovary.
    Abu-Rustum NR; Restivo A; Ivy J; Soslow R; Sabbatini P; Sonoda Y; Barakat RR; Chi DS
    Gynecol Oncol; 2006 Oct; 103(1):31-4. PubMed ID: 16537089
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recurrence and prognostic factors in borderline ovarian tumors.
    Ayhan A; Guvendag Guven ES; Guven S; Kucukali T
    Gynecol Oncol; 2005 Sep; 98(3):439-45. PubMed ID: 16009407
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Outcome of ovarian cancer patients who underwent incomplete surgical staging.
    Panprom P; Lertkhachonsuk R
    J Med Assoc Thai; 2008 Sep; 91(9):1323-30. PubMed ID: 18843859
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Clinicopathologic analysis of 130 cases of mucinous borderline ovarian tumors].
    Cao DY; Shen K; Tao T; Yang JX; Xiang Y; Huang HF; Wu M; Pan LY; Lang JH
    Zhonghua Fu Chan Ke Za Zhi; 2011 Jan; 46(1):15-8. PubMed ID: 21429428
    [TBL] [Abstract][Full Text] [Related]  

  • 13. [Borderline ovarian tumors. Retrospective analysis of 20 cases].
    Iervolino P; Palmieri M; Rotondi M; D'Alessandro P; Iuliano R
    Minerva Ginecol; 2001 Feb; 53(1 Suppl 1):97-9. PubMed ID: 11526732
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Behaviour of ovarian tumors of low malignant potential treated with conservative surgery.
    De Iaco P; Ferrero A; Rosati F; Melpignano M; Biglia N; Rolla M; De Aloysio D; Sismondi P
    Eur J Surg Oncol; 2009 Jun; 35(6):643-8. PubMed ID: 19013745
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Are borderline tumors of the ovary safely treated by laparoscopy?
    Maneo A; Vignali M; Chiari S; Colombo A; Mangioni C; Landoni F
    Gynecol Oncol; 2004 Aug; 94(2):387-92. PubMed ID: 15297177
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Borderline ovarian tumors in reproductive-age women. Fertility-sparing surgery and outcome.
    Chan JK; Lin YG; Loizzi V; Ghobriel M; DiSaia PJ; Berman ML
    J Reprod Med; 2003 Oct; 48(10):756-60. PubMed ID: 14619640
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Surgical management of malignant ovarian germ-cell tumors: 10 years' experience of 129 patients.
    Peccatori F; Bonazzi C; Chiari S; Landoni F; Colombo N; Mangioni C
    Obstet Gynecol; 1995 Sep; 86(3):367-72. PubMed ID: 7651644
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Conservative surgery for borderline ovarian tumors: a review.
    Tinelli R; Tinelli A; Tinelli FG; Cicinelli E; Malvasi A
    Gynecol Oncol; 2006 Jan; 100(1):185-91. PubMed ID: 16216320
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Laparoscopic restaging of borderline ovarian tumours: results of 30 cases initially presumed as stage IA borderline ovarian tumours.
    Querleu D; Papageorgiou T; Lambaudie E; Sonoda Y; Narducci F; LeBlanc E
    BJOG; 2003 Feb; 110(2):201-4. PubMed ID: 12618166
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The current status of surgical staging of ovarian serous borderline tumors.
    Lin PS; Gershenson DM; Bevers MW; Lucas KR; Burke TW; Silva EG
    Cancer; 1999 Feb; 85(4):905-11. PubMed ID: 10091769
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 22.